Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1100220110100040107
Dementia and Neurocognitive Disorders
2011 Volume.10 No. 4 p.107 ~ p.111
Regional Metabolic Changes using Proton Magnetic Resonance Spectroscopy in Patients with Amnestic Mild Cognitive Impairment
Han Hyoung-Suk

Joo Jung-Hyun
Park Su-Sin
Cheong Jin-Sung
Ha Yoon-Su
Lee Hak-Seung
Park Hyun-Young
Chang Hyuk
Abstract
Background: Amnestic mild cognitive impairment (aMCI) is thought to be a prodromal stage of Alzheimer disease (AD). It is very important to diagnose aMCI for early treatment. Magnetic resonance spectroscopy (MRS) is a non-invasive technique for measuring intracerebral metabolites for early detection of cognitive decline. We measured regional metabolic changes in aMCI and healthy control (HC) subjects to assess the disease progression by using 1H-MRS.

Methods: We studied 9 subjects who met the criteria for aMCI and 10 HC subjects. We measured the ratio of N-acetylaspartate (NAA), myo-inositol (mI), and choline (Cho) to creatine (Cr) in hippocampus and posterior cingulate gyrus.

Results: There was a significant elevation of the mI/Cr ratio in the hippocampus (p<0.05). However, there were no significant differences in NAA/Cr and Cho/Cr ratios in the left hippocampus and left posterior cingulated gyrus. Also, there was no significant difference in the mI/Cr ratio in the left posterior cingulated gyrus.

Conclusions: Using 1H-MRS, we revealed that there is a difference in metabolic state between patients with aMCI and health controls.
KEYWORD
Mild cognitive impairment, 1H-MRS, Dementia
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed